ATRX and glioma: Interestingly, although both H3.3 mutations alter the size and number of PML bodies relative to WT H3.3, the specific effects vary depending on the point mutation (G34R, K27M), the presence of additional mutations (e.g., ATRX), and the cell type (human glioma, mouse ES cells).